{
  "actions": [
    {
      "acted_at": "2020-02-12",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2020-02-12",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the House Committee on Energy and Commerce.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr5882-116",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "referral"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    }
  ],
  "congress": "116",
  "cosponsors": [
    {
      "bioguide_id": "B001287",
      "district": "7",
      "name": "Bera, Ami",
      "original_cosponsor": true,
      "sponsored_at": "2020-02-12",
      "state": "CA",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "C001121",
      "district": "6",
      "name": "Crow, Jason",
      "original_cosponsor": true,
      "sponsored_at": "2020-02-12",
      "state": "CO",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "K000376",
      "district": "16",
      "name": "Kelly, Mike",
      "original_cosponsor": true,
      "sponsored_at": "2020-02-12",
      "state": "PA",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "M001198",
      "district": "1",
      "name": "Marshall, Roger",
      "original_cosponsor": true,
      "sponsored_at": "2020-02-12",
      "state": "KS",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "M001190",
      "district": "2",
      "name": "Mullin, Markwayne",
      "original_cosponsor": true,
      "sponsored_at": "2020-02-12",
      "state": "OK",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "S001183",
      "district": "6",
      "name": "Schweikert, David",
      "original_cosponsor": true,
      "sponsored_at": "2020-02-12",
      "state": "AZ",
      "title": "Rep.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2020-02-12",
  "number": "5882",
  "official_title": "To amend title XIX of the Social Security Act to provide States with the option under the Medicaid program to pay for covered outpatient drugs through risk-sharing value-based agreements, and for other purposes.",
  "popular_title": null,
  "related_bills": [
    {
      "bill_id": "hr19-116",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    },
    {
      "bill_id": "s2543-116",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    },
    {
      "bill_id": "s4199-116",
      "identified_by": "CRS",
      "reason": "related",
      "type": "bill"
    }
  ],
  "short_title": "GENE Therapy Payment Act",
  "sponsor": {
    "bioguide_id": "S001180",
    "district": "5",
    "name": "Schrader, Kurt",
    "state": "OR",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2020-02-12",
  "subjects": [
    "Administrative law and regulatory procedures",
    "Appropriations",
    "Congressional oversight",
    "Department of Health and Human Services",
    "Drug safety, medical device, and laboratory regulation",
    "Drug therapy",
    "Genetics",
    "Government studies and investigations",
    "Health",
    "Health care costs and insurance",
    "Home and outpatient care",
    "Intergovernmental relations",
    "Manufacturing",
    "Medicaid",
    "Prescription drugs",
    "State and local government operations"
  ],
  "subjects_top_term": "Health",
  "summary": {
    "as": "Introduced in House",
    "asOf": "2020-02-12",
    "date": "2021-01-09T00:40:04Z",
    "text": "Generating Effective and Novel Evidence for Therapy Payment Act or the GENE Therapy Payment Act\n\nThis bill allows state Medicaid programs to pay for certain gene therapy drugs through risk-sharing value-based payment agreements with drug manufacturers. The bill applies to covered outpatient drugs that provide potentially curative treatment for serious or life-threatening rare diseases or conditions after not more than three administrations."
  },
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "GENE Therapy Payment Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To amend title XIX of the Social Security Act to provide States with the option under the Medicaid program to pay for covered outpatient drugs through risk-sharing value-based agreements, and for other purposes.",
      "type": "official"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "GENE Therapy Payment Act",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Generating Effective and Novel Evidence for Therapy Payment Act",
      "type": "short"
    }
  ],
  "updated_at": "2022-02-08T23:20:34Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/116/hr/BILLSTATUS-116hr5882.xml"
}